Which Factors Predict the Recovery of Natural Heart Function After Insertion of a Left Ventricular Assist System?

Journal of Heart and Lung Transplantation

Volumn 27, Issue 8, 2008, Pages 869-874

  Mano, A ^a   Nakatani, T ^a   Oda, N ^a   Kato, T ^a   Niwaya, K ^a   Tagusari, O ^a   Nakajima, H ^a   Funatsu, T ^a   Hashimoto, S ^a   Komamura, K ^a   Hanatani, A ^a   Ueda, I H ^a   Kitakaze, M ^a   Kobayashi, J ^a   Yagihara, T ^a   Kitamura, S ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BRAIN NATRIURETIC PEPTIDE; CARVEDILOL; DIGITALIS; ENALAPRIL; FUROSEMIDE; INOTROPIC AGENT; SPIRONOLACTONE;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DEVICE REMOVAL; DRUG DOSE TITRATION; ECHOCARDIOGRAPHY; FEMALE; FIBROSING ALVEOLITIS; HEART ASSIST DEVICE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART VENTRICLE HYPERTROPHY; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; TREATMENT OUTCOME;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARBAZOLES; FEMALE; HEART; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROPANOLAMINES; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 47649121726     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.05.007     Document Type: Article

References (19)

1. Nakatani T., Sasako Y., Kumon K., et al. Long-term circulatory support to promote recovery from profound heart failure. ASAIO J 41 (1995) M526-M530
2. Levin H., Oz M., Chen J., et al. Reversal of chronic ventricular dilatation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation 91 (1995) 2717-2720
3. Schenin S., Capek P., Radovancevic B., et al. The effect of prolonged left ventricular assist support on myocardial histopathology in patients with end stage cardiomyopathy. ASAIO J 38 (1992) M271-M274
4. Lee S., Oskbakken M., Doliba N., Oz M., and Mancini D. LVAD therapy improves myocardial mitochondrial metabolism in patients with heart failure. J Thorac Cardiovasc Surg 116 (1998) 1-6
5. Levin H., Chen J., Oz H., et al. Potential for left ventricular assist device as out-patient therapy while awaiting transplantation. Ann Thorac Surg 58 (1994) 1515-1520
6. Belland S., Grunstein R., Jeevanadam V., and Eisen H. The effect of sustained mechanical support with left ventricular assist devices on myocardial apoptosis in patients with severe dilated cardiomyopathy. J Heart Lung Transplant 17 (1998) 83A
7. George R.S., Yacoub M.H., Tasca G., et al. Hemodynamic and echocardiographic responses to acute interruption of left ventricular assist device support: relevance to assessment of myocardial recovery. J Heart Lung Transplant 26 (2007) 967-973
8. Wohlschlaeger J., Schmitz K.J., Schmid C., et al. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes. Cardiovasc Res 68 (2005) 376-386
9. Heerdt P.M., Holmes J.W., Cai B., et al. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation 102 (2000) 2713-2719
10. Brodde O.E. Beta-adrenergic receptors in failing human myocardium. Basic Res Cardiol 91 suppl 2 (1996) 35-40
11. Zafeiridis A., Jeevanandam V., Houser S.R., and Margulies K.B. Regression of cellular hypertrophy after left ventricular assist device support. Circulation 98 (1998) 656-662
12. Kucuker S.A., Stetson S.J., Becker K.A., et al. Evidence of improved right ventricular structure after LVAD support in patients with end-stage cardiomyopathy. J Heart Lung Transplant 23 (2004) 28-35
13. Loebe M., Muller J., and Hetzer R. Ventricular assistance for recovery of cardiac failure. Curr Opin Cardiol 14 (1999) 234-248
14. Entwistle III J.W. Short- and long-term mechanical ventricular assistance towards myocardial recovery. Surg Clin N Am 84 (2004) 210-221
15. Packer M., Bristow M.R., Cohn J.N., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334 (1996) 1349-1355
16. MERIT-HF. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 (1999) 2001-2007
17. CIBIS-II. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial. Lancet 353 (1999) 9-13
18. Reiken S., Wehrens X., Vest J., et al. β-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. Circulation 107 (2003) 2459-2466
19. Sabbah H.N. Biologic rationale for the use of beta-blockers in the treatment of heart failure. Heart Fail Rev 2 (2004) 91-97